Naseruddin Höti is a Chief Scientific Officer and CLIA Medical Director currently leading efforts at Complete Omics Inc. and Prevencio. With a PhD in Biochemistry and Molecular Biology from the University of Science and Technology of China, Naseruddin's research focuses on utilizing systems biology tools to investigate prostate cancer phenotypes. They have held prominent academic roles, including Senior Instructor at Johns Hopkins School of Medicine and Adjunct Assistant Professor at UT Health San Antonio. Naseruddin's extensive training in proteomics and translational medicine has positioned them at the forefront of discovering novel biomarkers and therapeutic targets for metastatic prostate cancer.
This person is not in any teams
This person is not in any offices